India’s first topical Minocycline 4% Gel for the treatment of moderate to severe acne, has been launched by Glenmark Pharmaceuticals Limited, under the brand name MINYM.
MINYM Gel is a potent antibacterial gel which exerts a strong anti-inflammatory action. It also offers the lowest MIC90 (minimum Inhibitory Concentration at which it stops/prevents visible growth of 90% of isolates of bacteria) compared to the available topical antibacterial formulations. MINYM Gel (Topical Minocycline 4% Gel) has been developed to address growing concerns in treatment of acne and is safe to use in patients above 9 years of age.
“We are proud to introduce the first topical Minocycline-based -MINYM Gel, in India; proven for its potent anti-bacterial effect, anti-inflammatory action and lowest resistance, as a treatment option to patients aged 9 years and above suffering from acne”, said Alok Malik, Group Vice-President & Head, India Formulations, Glenmark.
